Cell Expansion Market is Expected to Reach $26.7 billion | MarketsandMarkets™

Chicago, April 11, 2024 (GLOBE NEWSWIRE) — Cell Expansion market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a latest report published by MarketsandMarkets™. Factors like increasing prevalence of chronic diseases, growing demand for advanced therapies, and rising research activities in the field of cell biology are driving the growth of cell expansion market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194978883

Cell Expansion Market Scope:

Report Coverage Details
Market Revenue in 2024 $14.3 billion
Estimated Value by 2029 $26.7 billion
Growth Rate Poised to grow at a CAGR of 13.3%
Market Size Available for 2022–2029
Forecast Period 2024–2029
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, Cell Type, Application, and End User
Geographies Covered North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunity Growth opportunities in emerging economies
Key Market Driver Increasing rate of chronic diseases

Technological advancements, particularly in the utilization of automated systems and 3D bioprinting technology for cell expansion, are reshaping the cell expansion landscape. Advancements in automation technologies have enabled more precise control over bioreactor operations and reduced the need for manual intervention. Integrated monitoring systems continuously track key parameters such as cell density, viability, metabolite concentrations, and environmental conditions, allowing real-time adjustments to optimize cell growth and productivity. Meanwhile, 3D bioprinting technology allows precise spatial control over cell deposition, enabling the creation of complex tissue-like structures. By combining cell expansion with 3D bioprinting, researchers can fabricate tissue constructs for applications in tissue engineering, drug screening, and regenerative medicine. These breakthroughs are poised to revolutionize biotechnology industries, driving innovation in drug discovery and personalized medicine, ultimately transforming the business landscape.

Based on product, the cell expansion market is segmented into consumables and equipment. Consumables accounted for the largest share of the global cell expansion market in 2023. The large share of this segment can primarily be attributed to the increasing demand for high quality consumables such as media, sera, and reagents. Additionally, increasing research activities in the field of cell biology is anticipated to drive the segment growth.

Based on cell type, the global cell expansion market is segmented into human cells, animal cells, and other cell types. In 2023, human cells segment accounted for the largest share of the cell expansion market and is expected to register highest CAGR during the forecast period. The large share of this segment can be attributed to the increasing adoption of human cells for cell-based research.

Based on application, the cell expansion market has been segmented into biopharmaceutical production, tissue engineering & regenerative medicine, drug screening & development, and other applications. In 2023, biopharmaceutical production accounted for the largest share of cell expansion market. The highest share of the segment is attributed to various factors such as increasing incidences of chronic diseases and rising need of novel therapeutics.

Based on end user, the cell expansion market has been segmented into pharmaceutical and biotechnology companies, research & academic institutes, hospitals & diagnostic laboratories, and other end users. In 2023, pharmaceutical and biotechnology companies accounted for the largest share of the cell expansion market. The large share of this segment can be attributed to the rising demand for cell and gene therapies. Additionally, the growing focus of pharmaceutical and biotechnology companies for development of novel therapeutics for the treatment of chronic diseases is anticipated to boost the segment growth.

The key regional markets for the global cell expansion market are North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America accounted for the largest share of the market. The large share of this region can be attributed to the increasing demand for cell and gene therapy and rising focus on advancement of healthcare infrastructure. However, most of the growth in the market is expected from emerging countries across Asia Pacific. During the forecast period, the Asia Pacific is expected to be the fastest-growing regional market. Factors such as the increasing research practices in the field of biotechnology and life sciences are driving growth in these markets. Moreover, growing focus on advancement of biopharmaceutical industry is boosting the growth of cell expansion market in Asia Pacific region.

Buy a Cell Expansion Industry Report (563 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=194978883

Cell Expansion market major players covered in the report, such as:

  • Thermo Fisher Scientific Inc. (US)
  • Danaher Corporation (US)
  • Merck KGaA (Germany)
  • Sartorius AG (Germany)
  • Corning Incorporated (US)
  • Lonza (Switzerland)
  • Terumo Corporation (Japan)
  • Eppendorf SE (Germany)
  • FUJIFILM Corporation (Japan)
  • Bio-Techne (US)
  • Repligen Corporation (US)
  • Getinge AB (Sweden)
  • Miltenyi Biotec (Germany)
  • PerkinElmer Inc. (US)
  • STEMCELL Technologies (Canada)
  • PromoCell GmBH (Germany)
  • HiMedia Laboratories (India)
  • BD (US)
  • Takara Bio Inc. (Japan)
  • Shanghai Duoning Biotechnology Co., Ltd. (Japan)
  • REPROCELL Inc. (Japan)
  • PBS Biotech, Inc. (US)
  • ACROBiosystems (US)
  • Solida Biotech GmBH (Germany)
  • Beijing CytoNiche Biotechnology Co., Ltd. (China)
  • Neuromics (US)
  • Bionet (Spain)
  • Cellexus (UK)
  • and Among Others

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=194978883

This report categorizes the cell expansion market into the following segments:

Cell expansion market, by Product

  • Consumables
    • Media
      • Serum-free Media
      • Classical Media & Salts
      • Stem Cell Culture Media
      • Chemically Defined Media
      • Specialty Media
      • Other Media
    • Reagents
    • Sera
    • Vessels
      • Roller/roux bottles
      • Cell factory systems/cell stacks
      • Flasks
      • Multiwell plates
      • Cell Expasnion Bags
      • Petri dishes
    • Other Consumables
  • Equipment
    • Bioreactors
      • Bioreactors, by Usage
        • Conventional Bioreactors
        • Single Use Bioreactor
      • Bioreactors, by Type
        • Microcarrier bioreactor
        • Suspension based independent bioreactors
        • Hollow fiber bioreactor
        • Other Bioreactors
    • Automated cell expansion systems
    • Other Cell Expansion Equipment

Cell Expansion market, by Cell Type

  • Human Cells
    • Stem Cells
      • Adult Stem Cells
      • Embryonic Stem Cells
      • Induced Pluripotent Stem Cells
    • Differenciated Cells
  • Animal Cells
    • Chinese Hamster Ovary Cells (CHO)
    • Mouse Embryonic Stem Cells (mESCs)
    • Others Animal Cells
  • Other Cell Types

Cell Expansion market, by Application

  • Biopharmaceutical Production
    • Monoclonal Antibody Production
    • Vaccine Production
    • Other Therapeutic Protein Production 
  • Tissue Engineering & Regenerative Medicine
    • Cell And Gene Therapy
    • Other Tissue Engineering And Regenerative Medicine Applications
  • Drug Screening & Development
  • Other Applications

Cell expansion market, by End User

  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
  • Hospitals And Diagnostic Laboratories
  • Other End Users

Cell expansion market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East
    • GCC Countries
      • Saudi Arabia (KSA)
      • United Arab Emirates (UAE)
      • Rest of GCC Countries (RoGCC)
    • Rest of Middle East (RoME)
  • Africa

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=194978883

Key Market Stakeholders:

  • Cell Expansion Product Manufacturers, Vendors, and Distributors
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Diagnostic Laboratories
  • Venture Capitalists and Investors
  • Private Research Firms
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)

Report Objectives:

  • To define, describe, and forecast the global cell expansion market based on the product, cell type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities and challenges)
  • To strategically analyze micro-markets with respect to individual growth trends, future prospects, and contributions to the overall cell expansion market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the cell expansion market.

Related Reports:

Stem Cell Therapy Market

Biologics Safety Testing Market

Sterility Testing Market

Nerve Repair & Regeneration Market

Stem Cell Assays Market

Research Insights: https://www.marketsandmarkets.com/ResearchInsight/cell-expansion-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/cell-expansion.asp

CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy